It’s not a word that most people use every day, but myopia is becoming an increasingly more common condition.
Myopia, more commonly known as nearsightedness, is a condition where individuals are able to see objects that are close to them but may have difficulty distinguishing things at a distance, such as road signs or leaves on a tree. These individuals often squint at objects that are further away to try and help bring them into focus.
The reason objects are blurry in the distance with nearsightedness is because the eye becomes longer as the child grows.
When it comes to the prevalence of myopia, the statistics are staggering. In the U.S. alone, more than 40 percent of Americans have myopia and that number is increasing at an alarming rate, especially among school-aged children.
The reason for its escalation has been linked to two factors:
Genetics Children with one or two myopic parents are more likely to be myopic.
Lifestyle Children who spend more time on activities like reading or using handheld devices instead of spending time outdoors are more likely to become myopic.
SOLUTIONS TO MYOPIA
MiSight 1 day is the first and only contact lens FDA-approved*to slow the progression of myopia in children aged 8-12 at the initiation of treatment. Children can apply the soft, daily wear, single use contact lenses to their eyes in the morning, wear them for at least 10 hours during the day, then dispose of them in the evening.
MiSight 1 day is an award-winning dual-focus soft contact lens that uses ActivControl™ Technology to slow the elongation of the eyeball.
The ActivControl™ Technology in MiSight 1 day utilizes an optic zone concentric ring design with alternating vision correction and treatment zones. Two zones are vision correction zones with the label power of the contact lens, and the alternating two zones are treatment zones with 2 diopters of defocus to slow
the progression of myopia. This design allows the child to see clearly while benefiting from the treatment effect.
Start managing your Child’s myopia today
MiSight® 1 day soft contact lenses are specifically designed for myopia control and are FDA approved* to slow the progression of myopia in children aged 8-12 at the initiation of treatment.1†
Clinically proven1 and safe.3
Over a 3-year period, there was a 59% reduction in myopia progression on average.1† Over a 6-year period, children wearing MiSight® 1 day progressed less than 1.00D on average.4‡
Child friendly and easy to use.
After using MiSight® 1 day contact lenses for three years, 90% of children could insert and remove the MiSight® 1 day lens on their own.5| Additionally, after using MiSight® 1 day contact lenses for three years, 90% of children still strongly preferred them over their glasses.
1Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8):556-567.
2Donovan L, Sankaridurg P, Ho A, Naduvilath T, Smith EL 3rd, Holden BA. Myopia progression rates in urban children wearing single-vision spectacles. Optom Vis Sci. 2012 Jan;89(1):27-32. doi: 10.1097/OPX. 0b013e3182357f79. PMID: 21983120; PMCID: PMC3249020.
3CVI data on file 2019. Global survey by Decision Analyst with 402 ECPs in UK, Canada, Germany, Spain, Hong Kong, Australia/NZ.
4Chamberlain P, Arumugam B, Jones D et al. Myopia Progression in Children wearing Dual-Focus Contact Lenses: 6-year findings. Optom Vis Sci 2020;97(E-abstract): 200038.
5CVI data on file 2018. 3- year study report.
6Sulley A et al. Wearer experience and subjective responses with dual focus compared to spherical, single vision soft contact lenses in children during a 3-year clinical trial. AAO 2019 Poster Presentation.
Learn more about MiSight here: https://misight.com/